QURE - Company ID 0001590560
uniQure N.V. trades as QURE and has a market capitalization of $2.77 B, making it the #1900 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $16.10M, down 40.6% from the prior year and net income of -$199.00M. This page tracks uniQure N.V. through 886 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years uniQure N.V.'s revenue declined from $25.10M to $16.10M, a compound annual decline rate of 4.8%. Net profit margin compressed from 62.9% to -1236.2% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Insider trade | 4 | 2026-05-12 |
| SCHEDULE 13G | - | 2026-05-12 |
| Insider sale notice | 144 | 2026-05-08 |
| SCHEDULE 13G/A | - | 2026-05-06 |
| Quarterly report | 10-Q | 2026-05-05 |
| Major company event | 8-K | 2026-05-05 |
| SCHEDULE 13G/A | - | 2026-04-30 |
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates | uniqure BV
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease | uniqure BV
uniQure to Announce First Quarter 2026 Financial Results | uniqure BV
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease | uniqure BV
uniQure Announces 2025 Financial Results and Provides Recent Company Updates | uniqure BV
The largest companies sharing uniQure N.V.'s SEC industry classification (pharmaceutical preparations).
uniQure N.V. (QURE) has a market capitalization of $2.77 B as of 2026-07-09, ranking #1900 among US-listed companies.
uniQure N.V. reported revenue of $16.10M for fiscal year 2025, a decrease of 40.6% year over year.
In its latest fiscal year uniQure N.V. reported a net loss of $199.00M.